Minerva Neurosciences Reports Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates

World News: . []

WALTHAM Mass March 12 2018 GLOBE NEWSWIRE -- Minerva Neurosciences Inc NASDAQNERV a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat unmet medical needs of central nervous system CNS ) disor...

More news and information about Minerva Neurosciences, Inc

Published By:

Globe Newswire: 11:30 GMT Monday 12th March 2018

Published: .

Search for other references to "minerva" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us